Aims.
Aims. Prior to the availability of vaccines, mortality for
Aims. Current levels of
Aims. The aim of this study was to examine perioperative blood transfusion practice, and associations with clinical outcomes, in a national cohort of
Aims. The aim of this study was to determine the impact of hospital-level service characteristics on
Aims. This study aimed to identify risk factors (patient, healthcare system, and socioeconomic) for mortality after
Aims. Factors associated with high mortality rates in geriatric
Aims. Surgery is often delayed in patients who sustain a
Aims. The primary aim was to assess the independent influence of coronavirus disease (COVID-19) on 30-day mortality for patients with a
Aims. We assessed the value of the Clinical Frailty Scale (CFS) in the prediction of adverse outcome after
Aims. The aim of this study was to assess the association of mortality and reoperation when comparing cemented and uncemented hemiarthroplasty (HA) in
Aims. The use of multimodal non-opioid analgesia in
Aims. To assess the safety of tranexamic acid (TXA) in a large cohort of patients aged over 65 years who have sustained a
Aims. Echocardiography is commonly used in
Aims. National
Aims. Infection after surgery increases treatment costs and is associated with increased mortality.
Aims. Hospital case volume is shown to be associated with postoperative outcomes in various types of surgery. However, conflicting results of volume-outcome relationship have been reported in
Aims. This study sought to determine the proportion of older adults with
Aims. Low haemoglobin (Hb) at admission has been identified as a risk factor for mortality for elderly patients with
Aims.